Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study.

Holl K, Nowakowski AM, Powell N, McCluggage WG, Pirog EC, Collas De Souza S, Tjalma WA, Rosenlund M, Fiander A, Castro Sánchez M, Damaskou V, Joura EA, Kirschner B, Koiss R, O'Leary J, Quint W, Reich O, Torné A, Wells M, Rob L, Kolomiets L, Molijn A, Savicheva A, Shipitsyna E, Rosillon D, Jenkins D.

Int J Cancer. 2015 Dec 15;137(12):2858-68. doi: 10.1002/ijc.29651. Epub 2015 Jul 14.

2.

Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.

Simonella LM, Lewis H, Smith M, Neal H, Bromhead C, Canfell K.

BMC Infect Dis. 2013 Mar 3;13:114. doi: 10.1186/1471-2334-13-114.

3.

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.

Quek SC, Lim BK, Domingo E, Soon R, Park JS, Vu TN, Tay EH, Le QT, Kim YT, Vu BQ, Cao NT, Limson G, Pham VT, Molijn A, Ramakrishnan G, Chen J.

Int J Gynecol Cancer. 2013 Jan;23(1):148-56. doi: 10.1097/IGC.0b013e31827670fd.

PMID:
23221730
4.

[Distribution of human papillomavirus (HPV) among HPV positive cervical adenocarcinoma cases detected by laser capture microdissection(LCM)].

Liu B, Wu ZN, Liu XY, Sun HK, Li Q, Lin CQ, Zeng L, Cui JF, Yu XH, Zhang X, Li L, Chen W.

Zhonghua Zhong Liu Za Zhi. 2016 Apr;38(4):277-82. doi: 10.3760/cma.j.issn.0253-3766.2016.04.007. Chinese.

PMID:
27087374
5.

A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science.

Allameh T, Moghim S, Asadi-Zeidabadi M.

Arch Gynecol Obstet. 2011 Dec;284(6):1509-13. doi: 10.1007/s00404-011-1863-4. Epub 2011 Mar 9.

PMID:
21387088
6.

Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.

Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, Koiss R, O'Leary J, Joura EA, Rosenlund M, Colau B, Schledermann D, Kukk K, Damaskou V, Repanti M, Vladareanu R, Kolomiets L, Savicheva A, Shipitsyna E, Ordi J, Molijn A, Quint W, Raillard A, Rosillon D, De Souza SC, Jenkins D, Holl K; HERACLES/SCALE Study Group.

Int J Cancer. 2013 Feb 15;132(4):854-67. doi: 10.1002/ijc.27713. Epub 2012 Jul 24.

7.

Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.

Zhao C, Li Z, Austin RM.

Am J Clin Pathol. 2013 Jul;140(1):47-54. doi: 10.1309/AJCPIP9M8HPVBSSC.

PMID:
23765533
8.

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX; Retrospective International Survey and HPV Time Trends Study Group.

Lancet Oncol. 2010 Nov;11(11):1048-56. doi: 10.1016/S1470-2045(10)70230-8. Epub 2010 Oct 15.

PMID:
20952254
9.

Human papillomavirus genotypes associated with cervical neoplasia in India.

Peedicayil A, Abraham P, Sathish N, John S, Shah K, Sridharan G, Gravitt P.

Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1591-5.

PMID:
16884371
10.

Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.

Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, Snyman L, Wiredu E, Molijn A, Quint W, Ramakrishnan G, Schmidt J.

Int J Cancer. 2014 Mar 15;134(6):1389-98. doi: 10.1002/ijc.28425. Epub 2013 Nov 14.

11.

HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland.

Anderson LA, O'Rorke MA, Wilson R, Jamison J, Gavin AT; Northern Ireland HPV Working Group.

J Med Virol. 2016 Jul;88(7):1262-70. doi: 10.1002/jmv.24447. Epub 2016 Jan 5.

PMID:
26680281
12.

Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.

Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL.

J Med Virol. 2011 Jun;83(6):1034-41. doi: 10.1002/jmv.22081.

PMID:
21503917
13.

Human papillomavirus prevalence and type-distribution in women with cervical lesions: a cross-sectional study in Sri Lanka.

Karunaratne K, Ihalagama H, Rohitha S, Molijn A, Gopala K, Schmidt JE, Chen J, Datta S, Mehta S.

BMC Cancer. 2014 Feb 21;14:116. doi: 10.1186/1471-2407-14-116.

14.

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.

J Natl Cancer Inst. 2009 Apr 1;101(7):475-87. doi: 10.1093/jnci/djn510. Epub 2009 Mar 24.

15.

Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18.

Chen W, Zhang X, Molijn A, Jenkins D, Shi JF, Quint W, Schmidt JE, Wang P, Liu YL, Li LK, Shi H, Liu JH, Xie X, Niyazi M, Yang P, Wei LH, Li LY, Li J, Liu JF, Zhou Q, Hong Y, Li L, Li Q, Zhou HL, Bian ML, Chen J, Qiao YL, Smith JS.

Cancer Causes Control. 2009 Nov;20(9):1705-13. doi: 10.1007/s10552-009-9422-z. Epub 2009 Aug 25.

PMID:
19705288
16.

Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study.

Quddus MR, Manna P, Sung CJ, Kerley S, Steinhoff MM, Lawrence WD.

Hum Pathol. 2014 Feb;45(2):303-9. doi: 10.1016/j.humpath.2013.07.048. Epub 2013 Oct 1.

PMID:
24355194
17.

Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities.

Spinillo A, Gardella B, Roccio M, Alberizzi P, Cesari S, Patrizia M, Silini E.

Cancer Causes Control. 2014 Dec;25(12):1669-76. doi: 10.1007/s10552-014-0471-6. Epub 2014 Oct 9.

PMID:
25296710
18.

Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance.

Xu XX, Zhou JS, Yuan SH, Yu H, Lou HM.

Int J Environ Res Public Health. 2015 Sep 2;12(9):10794-805. doi: 10.3390/ijerph120910794.

19.

Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand.

Kang YJ, Lewis H, Smith MA, Simonella L, Neal H, Bromhead C, Canfell K.

BMC Infect Dis. 2015 Aug 22;15:365. doi: 10.1186/s12879-015-1034-5.

20.

Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact.

Pérez-Castro S, Lorenzo-Mahía Y, Iñarrea Fernández A, Lamas-González MJ, Sarán-Díez MT, Rubio-Alarcón J, Reboredo-Reboredo MC, Mosteiro-Lobato S, López-Miragaya I, Torres-Piñón J, Melón-García S.

Enferm Infecc Microbiol Clin. 2014 Oct;32(8):479-85. doi: 10.1016/j.eimc.2013.09.011. Epub 2013 Nov 22.

PMID:
24274937

Supplemental Content

Support Center